Deucravacitinib by Bristol-Myers Squibb can help with psoriasis, psoriatic arthritis, Crohn’s disease, ulcerative colitis, and systemic lupus erythematosus.
Johnson & Johnson
Posted inNew Drugs, Oncology, Rare/Orphan Diseases, Regulatory
Tecvayli: New Drug for Multiple Myeloma
Teclistamab by Johnson & Johnson is a new hope for refractory or relapsing multiple myeloma.
Posted inNeuroscience, New Drugs, Regulatory
Quviviq: New Sleeping Pill
Daridorexant will help treat insomnia.
Posted inCOVID-19, Infections, Research
Three Billion Omicron Cases
Omicron, a new variant of the SARS-CoV-2 coronavirus, will infect nearly 40% of the world’s population.
Posted inAutoimmune Diseases, New Drugs, Rare/Orphan Diseases, Regulatory
Vyvgart: New Drug to Treat Myasthenia Gravis
Efgartigimod developed by Argenx is a strong competitor to Soliris.
Posted inCOVID-19, Infections, Research
Omicron Variant: Latest Scientific News, Findings, Evidence, and Developments
Up-to-date scientific information about the new Omicron variant of SARS-CoV-2/COVID-19.
Posted inAutoimmune Diseases, New Drugs, Regulatory
Zeposia: New Drug for Ulcerative Colitis
Oral ozanimod will provide clinical remission of ulcerative colitis for a third of patients.